Publications by authors named "John Lawrence D De Borja"
Molecular Docking and Pharmacokinetic Profiling of Nab-paclitaxel as Advanced Chemotherapeutic Agent Against HER-2 Positive Breast Cancer Patients.
Nicole Jacob Dj Mangilit Ana Beatrice S Arkoncel Karyll Mikaela Dl Baylon Jan Marnylle V Eslabra John Lawrence D De Borja
Asian Pac J Cancer Prev
October 2024
Objective: The main objective of the study is to explore the potential molecular benefits of Nab-paclitaxel as an effective advanced chemotherapeutic agent for HER2-positive breast cancer patients. Specifically, the study aims to assess Nab-paclitaxel as a potential drug candidate for breast cancer treatment.
Methods: This study used bioinformatics and cheminformatics to analyze the HER2 signaling pathway and its possible interactions with Nab-Paclitaxel.